PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

39 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
21.
Vosberg, S. et al.: Genetic and epigenetic evolution during the progression of cytogenetically normal acute myeloid leukemia (CN-AML). Haematologica 100, 35 (2015)
22.
Zoellner, A.-K. et al.: Efficacy of the pan pi3k-inhibitor copanlisib compared to selective pi3k-a, -b, -delta inhibitors in mantle cell lymphoma (MCL). Haematologica 100, 551 (2015)
23.
Zoellner, A.-K. et al.: The B-cell receptor pathway is highly actived in canine dlbcl cell line CLBL-1. Haematologica 100, 762-763 (2015)
24.
Finkenzeller, C. ; Carlet, M. & Jeremias, I.: Optimization of lentiviral transduction in patien-derived acute leukemia cells growing mice. Haematologica 99, 543 (2014)
25.
Hubmann, M.* et al.: Molecular response assessment by quantitativerael-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies patients at high risk for relapse. Haematologica 99, 1317-1325 (2014)
26.
Lichtenegger, F.S. et al.: Pseudo-exhaustion of T cells in relapsed AML. Haematologica 99, 288-289 (2014)
27.
Lichtenegger, F.S.* et al.: Next-generation dendritic cell vaccination as postremission therapy for AML patients with a non-favorable risk profile. Haematologica 99, 435-436 (2014)
28.
Vick, B.* et al.: Serial transplantation and in vivo monitoring of patient-derived xenografts: An advanced preclinical model to study diverse genetic AML subgroups in mice. Haematologica 99, 20 (2014)
29.
Greif, P.A. et al.: RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with poor prognosis and up-regulation of lymphoid genes. Haematologica 97, 1909-1915 (2012)
30.
Schendel, D.J.: Is it time to abandon RHAMM/HMMR as a candidate antigen for immunotherapy of acute myeloid leukemia? Haematologica 97, 1454-1455 (2012)
31.
Slotta-Huspenina, J.* et al.: The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: P53 alterations and blastoid morphology are strong predictors of a high proliferation index. Haematologica 97, 1422-1430 (2012)
32.
Anastasov, N. et al.: C/EBPβ expression in ALK-positive anaplastic large cell lymphomas (ALCL) is required for cell proliferation and is induced by the STAT3 signaling pathway. Haematologica 95, 760-767 (2010)
33.
Bink, K. et al.: Primary extramedullary plasmacytoma: Similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Haematologica 93, 623-626 (2008)
34.
La Starza, R.* et al.: Dual-color split signal fluorescence in situ hybridization assays for the detection of CALM/AF10 in t(10;11)(p13;q14-q21)-positive acute leukemia. Haematologica 91, 1248-1251 (2006)
35.
Arseni, N. ; Ahmed, F. ; Hiddemann, W. ; Buske, C. & Feuring-Buske, M.: Effects of the protein tyrosine kinase inhibitor, SU5614, on leukemic and normal stem cells. Haematologica 90, 1577-1578 (2005)
36.
Herzog, G. et al.: Microsatellite instability and p53 mutations are characteristics of subgroups of acute myeloid leukemia but independent events. Haematologica 90, 693-695 (2005)
37.
Classen, C.F.* et al.: Natural killer resistance of a drug-resistant leukemia cell line, mediated by up-regulation of HLA class I expression. Haematologica 88, 509-521 (2003)
38.
Mergenthaler, H.G. & Dörmér, P.G.: Hemopoiesis in human micro long-term bone marrow culture with preformed extracellular matrix. Haematologica 75, 12-16 (1990)
39.
Thiel, E.V. ; Rodt, H.V. & Thierfelder, S.S.: Leukemic cell phenotypes and the lymphoid differentiation pathway. Haematologica 66, 389-408 (1981)